1

2

Life Science Investment Organisation

Dr Hakim Yadi November 30th 2012

Who are UKTI?

• Team that covers:

– Trade (UK-based companies selling overseas)

– Investment (Foreign Owned Companies investing in the UK)

3

Who are UKTI?

• When working on new investment, we cover:

– Politics, policy and barriers to growth

– Access to Ministers

– Campaigns

– R&D collaborations

– Project management of new investment

projects

4

• We are organised sectorally, including Life Science and Health

– Backed up by sector experts in sub segments

– Within this there is currently a special focus on life science and

health: the Life Sciences Investment Organisation (LSIO)

November 07, 2012

How Do We Promote Investment Into The UK?

5

UK Inward Investment Network: Our Overseas Network

6

Source: Great Britain & Northern Ireland – UK Inward Investment Network, Our Team, July 2012

232 FTE (FDI)

3 Regional Hubs (Hong Kong, New York & Paris)

Source Markets For Inbound FDI 2007-2011

7

Source: fDi Markets, a service from the Financial Times September 2012, Microsoft Map Point

8

UK Inward Investment: Life Sciences

Sector Trends

0

100

200

300

400

500

600

700

800

Pro

jects

Life Sciences

Forecast

Using the UK Life Science Strategy to support international UK Offers

9

A sector under pressure

10

Why invest in UK Life Sciences?

The UK Life Science Strategy – a

response to a challenged sector.

The Life Sciences Strategy is the UK’s

response to a global problem of rising

costs and complexity of research and

development, and the need for

products and services to address

patients needs and the needs of an

ageing population.

11

We have the know-how

12

• 4 of the world’s top 10 universities

• Leading country in the G8 for research productivity

• The UK accounts for 6% of world publications and

a global share of 14% of the most-cited papers

• Scientists in the UK have been awarded more than

76 Nobel Prizes (35 and counting for medical

research)

• The UK has a rich heritage in transformative

science with a proven track record in drug

discovery – more than 20% of biopharmaceuticals

in development originated in the UK

Life Science Investment Organisation

• UKTI has established a new initiative – the

Life Science Investment Organisation (LSIO)

• The LSIO is charged with:

– Creating a clearer presentation of the

UK’s capabilities and offering to the

Global Life Sciences sector

– Targeted business development based on

UK strengths and global market needs

– Creating and empowering a community of

UK Life Science ambassadors

13

LSIO Targeted Business Development

• Plans based on areas of differentiation for the UK Life Science base:

− Dementia Neurology

− Stratified Medicine

− Experimental Medicine

− Medical Technologies and convergence

• UKTI will target both existing Life Science companies (e.g. Pharma) and

disruptive companies (e.g. telehealth/eHealth) that would benefit from

working with the UK

• In addition, UKTI will work with the investment community to understand

how the UK’s science offering can generate new investment-fund related

opportunities

• The business plan will be continuously refreshed and updated on a monthly

cycle

14

Delivering the Targeted business development campaign

• Step 1: Define UK offer and create top line messages. Based on:

− Basic and applied research, Academic-clinical partnerships with industry,

Patient stratification and NHS access, SMEs and industry sectors

− Step 2: Create selling and delivery toolkit

− Step 3: Identify companies and individuals to target with the proposition

− Step 4: Engage companies, present the proposition and follow through

on investment opportunities

− Step 5: Report back to stakeholders on any gaps in the proposition to

ensure the UK Life Science Strategy is in tune with industry needs

15

Creating a community

Promotion of the UK Life Science strategy

will not happen fast enough or reach the

audience we hope to through UKTI alone

UKTI have identified a community that

can benefit from being part of an

extended virtual team, these individuals

will be approached to help promote the

unified proposition

We need to change the misconceptions of

the sector and promote positive messages

of UK success

16

Global Life

Sciences

How can we help

17

Working in partnership

18

• UKTI combines the expertise of professional trade and industry advisers in the

UK alongside a global network of experts based in British diplomatic offices

overseas, giving you access to a well-connected presence on the ground at

home and in the UK.

• Our practical help and advice for inward investment is free and confidential.

We work closely with other government departments and the wider UK Life

Science community to provide excellent service and present the best UK offer.

• Your business’ journey is important to us, from when your business is first

considering making an investment in the UK to once it is well established – we

are here to support your business’ ongoing and future activities

Working in partnership

19

• UKTI has established a dedicated unit focused on UK life sciences. The UKTI

Life Science Investment Organisation (LSIO) is your partner acting as a simple

interface to the UK Life Science sector.

• The LSIO is your guide to identifying research, development and delivery

partners and will support you through every step of investing in and working

in the UK.

• “UKTI connects your business to subject matter and experts across the Life

Sciences and healthcare sector in the UK.”

20